Mempel Thorsten R, Pittet Mikael J, Khazaie Khashayarsha, Weninger Wolfgang, Weissleder Ralph, von Boehmer Harald, von Andrian Ulrich H
CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.
Immunity. 2006 Jul;25(1):129-41. doi: 10.1016/j.immuni.2006.04.015.
Mechanisms of dominant tolerance have evolved within the mammalian immune system to prevent inappropriate immune responses. CD4(+)CD25(+) regulatory T (T(reg)) cells have emerged as central constituents of this suppressive activity. By using multiphoton intravital microscopy in lymph nodes (LNs) of anesthetized mice, we have analyzed how cytotoxic T lymphocytes (CTLs) interact with antigen-presenting target cells in the presence or absence of activated T(reg) cells. Nonregulated CTLs killed their targets at a 6.6-fold faster rate than regulated CTLs. In spite of this compromised effector activity, regulated CTLs exhibited no defect in proliferation, induction of cytotoxic effector molecules and secretory granules, in situ motility, or ability to form antigen-dependent conjugates with target cells. Only granule exocytosis by CTLs was markedly impaired in the presence of T(reg) cells. This selective form of regulation did not require prolonged contact between CTLs and T(reg) cells but depended on CTL responsiveness to transforming growth factor-beta. CTLs quickly regained full killing capacity in LNs upon selective removal of T(reg) cells. Thus, T(reg) cells reversibly suppress CTL-mediated immunity by allowing acquisition of full effector potential but withholding the license to kill.
哺乳动物免疫系统中已进化出显性耐受机制,以防止不适当的免疫反应。CD4(+)CD25(+)调节性T(T(reg))细胞已成为这种抑制活性的核心组成部分。通过在麻醉小鼠的淋巴结(LN)中使用多光子活体显微镜,我们分析了在有或没有活化的T(reg)细胞存在的情况下,细胞毒性T淋巴细胞(CTL)如何与抗原呈递靶细胞相互作用。未受调节的CTL杀死靶细胞的速度比受调节的CTL快6.6倍。尽管效应活性受损,但受调节的CTL在增殖、细胞毒性效应分子和分泌颗粒的诱导、原位运动或与靶细胞形成抗原依赖性结合物的能力方面均无缺陷。在T(reg)细胞存在的情况下,只有CTL的颗粒胞吐作用明显受损。这种选择性调节形式不需要CTL与T(reg)细胞长时间接触,而是依赖于CTL对转化生长因子-β的反应性。在选择性去除T(reg)细胞后,CTL在LN中迅速恢复了完全的杀伤能力。因此,T(reg)细胞通过允许获得完全的效应潜能但扣留杀伤许可,可逆地抑制CTL介导的免疫。